Intelon is a diagnostic and surgical device company marketing novel and proprietary biomechanics imaging technology for the eye, developed at Harvard Medical. These unique solutions - for primary care and specialist physicians - allow complete control and a high level of decision-making confidence based on biomechanical tissue properties. The end markets available for our solutions are forecast to be valued in the aggregate at $7.1B in 2017.